Industry Conference

Career colleges are booming as students flee AI, yet face intense pressure to adopt it. A new firm claims its bespoke approach can deliver massive ROI without the chaos.

Shokz's partnership with the Western States 100 isn't just a sponsorship; it's a masterclass in niche marketing. We deconstruct why a market-dominant brand is betting on 369 runners.

Amid the clamor of New York Tech Week, one curated gathering cut through the noise, shifting the focus for app founders from buzz to business.

As two trailblazing leaders conclude their terms, they leave a legacy of tech adoption and career support while navigating a complex new landscape for diversity.

With a key webinar ahead, Arrowhead Pharma is showcasing a trio of gene-silencing drugs. Can its TRiM™ platform upend a multi-billion dollar cardiometabolic market?

Two women-led Canadian brands are partnering, but the real story isn't the sale. It's a masterclass in resilient, values-driven business for a new era.

ICON International's new entertainment arm uses media trade and novel financial models to fund content, creating a new roadmap for brands and creators alike.

As air disc brakes become the new standard, DRiV's Abex brand moves beyond parts to offer an integrated system, simplifying maintenance and boosting safety.

With a new CEO known for scaling data-driven platforms, OWL AI is moving beyond officiating to become the foundational intelligence layer for live sports.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

Latin American software acquirer Nuvini is betting its future on 100% employee AI adoption, using an internal prize to transform its entire workforce.

Hisense's VAR role at the World Cup is more than a tech deal. It's a high-stakes play to enhance game integrity, dominate a market, and redefine fan experience.

As WestJet and the Blue Jays prepare a 'big-league reveal,' we analyze the strategic infrastructure of a partnership shaping fan loyalty and air travel.

An award for a small UK agency reveals a powerful trend: the future isn't about generic platforms, but purpose-built digital ecosystems that create real value.

Opendorse is pivoting from an NIL marketplace to a commerce engine, launching Athlete Commerce Media to directly link college athlete influence to sales at major retailers.

A Taipei delegation at BIO 2026 signals Taiwan's strategic pivot from manufacturing to R&D, seeking global partners for its late-stage drugs and platforms.

A new entity, THRYVE Automation, emerges from three legacy firms, betting its unified 'partnership' model can solve manufacturing's AI and labor crisis.

At BIO 2026, Transpire Bio isn't just presenting; it's pitching a new paradigm for medicine, using inhalation to tackle everything from diabetes to cancer.

Early trial data for a novel antibody-drug conjugate shows a 32% response rate in a hard-to-treat patient group, signaling a potential new front in precision oncology.

A new global study reveals a dangerous gap: while executives race to adopt AI, their companies lack the strategy, talent, and tech to make it work.